Evidence map›Paper›PMID 29384876›Full record

Observational studyMedicine2018

Predictors of completing a primary health care diabetes prevention intervention programme in people at high risk of type 2 diabetes: Experiences of the DE-PLAN project.

Aleksandra Gilis-Januszewska, Jaana Lindström, Noël C Barengo, Jaakko Tuomilehto, Peter Eh Schwarz, Ewa Wójtowicz, Beata Piwońska-Solska, Zbigniew Szybiński, Adam Windak, Alicja Hubalewska-Dydejczyk

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 7 countries.

Aleksandra Gilis-JanuszewskaDepartment of Endocrinology, Jagiellonian University, Medical College, Kopernika, Krakow, Poland Chronic Disease Prevention Unit, National Institute for Health and Welfare (THL), Helsinki, Finland Department of Medical and Population Health Science, Herbert Wertheim College of Medicine, Florida International University, Miami, USA Dasman Diabetes Institute, Dasman, Kuwait Centre for Vascular Prevention, Danube-University Krems, Krems, Austria Department of Chronic Disease Prevention, National Institute for Health and Welfare Department of Public Health, University of Helsinki, Helsinki, Finland Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia Department for Prevention & Care of Diabetes, Medical Clinic Unit III, University Clinic, Carl Gustav Carus at Technical University Dresden Paul Langerhans Institute Dresden of the Helmholtz Center Munich at University Hospital and Faculty of Medicine, Technical University Dresden, Dresden German Center for Diabetes Research, Neuherberg, Germany Department of Endocrinology Department of Family Medicine, Chair of Medicine and Gerontology, Jagiellonian University, Medical College, Krakow, Poland.
Jaana Lindström
Noël C Barengo
Jaakko Tuomilehto
Peter Eh Schwarz
Ewa Wójtowicz
Beata Piwońska-Solska
Zbigniew Szybiński
Adam Windak
Alicja Hubalewska-Dydejczyk
Finnish Institute for Health and Welfare · FIFlorida International University · USJagiellonian University · PLPaul Langerhans Institute Dresden · DEUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been shown that real-life implementation studies for the prevention of type 2 diabetes (DM2) performed in different settings and populations can be effective. However, not enough information is available on factors influencing the reach of DM2 prevention programmes. This study examines the predictors of completing an intervention programme targeted at people at high risk of DM2 in Krakow, Poland as part of the DE-PLAN project.A total of 262 middle-aged people, everyday patients of 9 general practitioners' (GP) practices, at high risk of DM2 (Finnish Diabetes Risk Score (FINDRISK) >14) agreed to participate in the lifestyle intervention to prevent DM2. Intervention consisted of 11 lifestyle counseling sessions, organized physical activity sessions followed by motivational phone calls and letters. Measurements were performed at baseline and 1 year after the initiation of the intervention.Seventy percent of the study participants enrolled completed the core curriculum (n = 184), 22% were men. When compared to noncompleters, completers had a healthier baseline diabetes risk profile (P <.05). People who completed the intervention were less frequently employed versus noncompleters (P = .037), less often had hypertension (P = .043), and more frequently consumed vegetables and fruit daily (P = .055).In multiple logistic regression model, employment reduced the likelihood of completing the intervention 2 times (odds ratio [OR] 0.45, 95% confidence interval [CI] 0.25-0.81). Higher glucose 2 hours after glucose load and hypertension were the independent factors decreasing the chance to participate in the intervention (OR 0.79, 95% 0.69-0.92 and OR 0.52, 95% CI 0.27-0.99, respectively). Daily consumption of vegetables and fruits increased the likelihood of completing the intervention (OR 1.86, 95% 1.01-3.41).In conclusion, people with healthier behavior and risk profile are more predisposed to complete diabetes prevention interventions. Male, those who work and those with a worse health profile, are less likely to participate and complete interventions. Targeted strategies are needed in real-life diabetes prevention interventions to improve male participation and to reach those who are working as well as people with a higher risk profile.

Indexed as

CounselingHealth BehaviorLife StylePrimary Health CareAdultAgedDiabetes Mellitus, Type 2ExerciseFemaleHumansMaleMiddle AgedPolandRisk Reduction Behavior

Identifiers

PMID29384876
PMCPMC5805448
OpenAlexW2789577829

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.